Systematic (IUPAC) name | |
---|---|
(2S)-1-[(3S,6S,9S,12S,15S)-12-[(2S)-butan-2-yl]- 9-(2-carbamoylethyl)-6-(carbamoylmethyl)-15- [(4-hydroxyphenyl)methyl]-16-methyl-5,8,11,14,17- pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane- 3-carbonyl]-N-[(1S)-1-(carbamoylmethylcarbamoyl)- 3-methyl-butyl]pyrrolidine-2-carboxamide |
|
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy cat. | ? |
Legal status | POM (UK) Not available (U.S.) |
Routes | Intravenous, intramuscular |
Pharmacokinetic data | |
Bioavailability | 80% (IM) |
Half-life | 40 minutes |
Identifiers | |
CAS number | 37025-55-1 |
ATC code | H01BB03 |
PubChem | CID 71715 |
DrugBank | DB01282 |
ChemSpider | 64765 |
UNII | 88TWF8015Y |
KEGG | D07229 |
Chemical data | |
Formula | C45H69N11O12S |
Mol. mass | 988.162 g/mol |
|
|
(verify) |
(what is this?)
Carbetocin (Duratocin) is an obstetric drug used to control postpartum hemorrhage, bleeding after giving birth.[1] It is an analogue of oxytocin, and its action is similar to that of oxytocin, such as contraction of the uterus.[2][3]
Carbetocin is available in Canada and the United Kingdom, but not in the United States.
|
|
|